Expression, Extracellular Secretion, and Immunogenicity of the<i>Plasmodium falciparum</i>Sporozoite Surface Protein 2 in<i>Salmonella</i>Vaccine Strains
Oscar G. Gómez‐Duarte(University at Buffalo, State University of New York), Myron M. Levine(University of Maryland, Baltimore), Stephen L. Hoffman(Sanaria), Marcelo B. Sztein(University of Maryland, Baltimore), Araceli E. Santiago(Institut de Recherche Vaccinale), Marcela F. Pasetti(University of Maryland Global Campus)
Cited by 21
Related Papers
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
|Science|2013|783
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
|Nature|1987|503
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls
|Infection and Immunity|2004|447
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
|Nature Reviews Microbiology|2007|372